Links between Propionibacterium acnes and prostate cancer

Future Oncology

Volumn 2, Issue 2, 2006, Pages 225-232

  Shannon, Beverley A ^a   Garrett, Kerryn L ^a   Cohen, Ronald J ^b  

^a Tissugen Pty Ltd   (Australia)

^b Uropath Pty Ltd   (Australia)

Author keywords

Inflammation; Propionibacterium acnes; Prostate cancer

Indexed keywords

ARTICLE; AUTOPSY; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CARCINOGENESIS; DISEASE ASSOCIATION; DNA EXTRACTION; HISTOPATHOLOGY; HUMAN; INCIDENTAL FINDING; INFLAMMATION; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; PROSTATE; PROSTATE CANCER; PROSTATITIS; PUBERTY; URINARY TRACT; MICROBIOLOGY; PATHOGENICITY; PROSTATE TUMOR; REVIEW;

GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; PROPIONIBACTERIUM ACNES; PROSTATIC NEOPLASMS;

EID: 33646456383     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/14796694.2.2.225     Document Type: Article

References (41)

1. Gronberg H: Prostate cancer epidemiology. Lancet 361, 859-864 (2003).
2. McNeal J: Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread. Hum. Pathol. 23, 258-266 (1992).
3. Chen YC, Hunter DJ: Molecular epidemiology of cancer. CA Cancer J. Clin. 55(1), 45-54 (2005).
4. Menaker RJ, Sharaf AA, Jones NL: Helicobacter pylori infection and gastric cancer: host, bug, environment, or all three? Curr. Gastroenterol. Rep. 6(6), 429-425 (2004).
5. Hochreiter WW, Duncan JL, Schaeffer AJ: Evaluation of the bacterial flora of the prostate using a 16S rRNA gene based polymerase chain reaction. J. Urol. 163, 127-130 (2000).
6. Lee JC, Muller CH, Rothman I et al.: Prostate biopsy culture findings of men with chronic pelvic pain syndrome do not differ from those of healthy controls. J. Urol. 169, 584-588 (2003).
7. Gorelick JI, Senterfit LB, Vaughan ED: Quantitative bacterial tissue cultures from 209 prostatectomy specimens: findings and implications. J. Urol. 139, 57-60 (1988).
8. Kohnen P, Drach G: Patterns of inflammation in prostatic hyperplasia: a histologic and bacteriologic study. J. Urol. 121, 755-760 (1979).
9. Cohen RJ, Shannon BA, McNeal JE, Shannon T, Garrett KL: Propionibacterium acnes associated with inflammation in radical prostatectomy specimens: a possible link to cancer evolution? J. Urol. 173, 1969-1974 (2005).
10. Cooper PN, Millar MR, Godwin PGR: Anaerobes and carcinoma of the prostate. Br. Med. J. 296, 466-467 (1988).
11. Platz EA. de Marzo AM: Epidemiology of inflammation and prostate cancer. J. Urol. 171, S36-S40 (2004).
12. Bastacky SI, Wojno KJ, Walsh PC, Carmichael MJ, Epstein JI: Prostate cancer: pathological features of hereditary prostate cancer. J. Urol. 153, 987-992 (1995).
13. Bostwick DG, Shan A, Qian J et al.: Independent origin of multiple foci of prostatic intraepithelial neoplasia: comparison with matched foci of prostate carcinoma. Cancer 83(9), 1995-2002 (1998).
14. Faraji EI, Frank BB: Multifocal atrophic gastritis and gastric carcinoma. Gastroenterol. Clin. North Am. 31 (2), 499-516 (2002).
15. Larson AA, Liao SY, Stanbridge EJ, Cavenee WK, Hampton GM: Genetic alterations accumulate during cervical tumorigenesis and indicate a common origin for multifocal lesions. Cancer Res. 57(19), 4171-4176 (1997).
16. Colombo M: Hepatocellular carcinoma in patients with HCV. Ballieres Best Pract. Clin. Gastroenterol. 14(2), 327-339 (2000).
17. Bostrom K: Chronic Inflammation of human male accessory sex glands and its effect on the morphology of the spermatozoa. Scand. J. Urol. Nephrol. 5, 133-140 (1971).
18. Zheng SL, Augustsson-Balter K, Chang B et al.: Sequence variants of Toll-like receptor 4 are associated with prostate cancer risk: results from the Cancer Prostate in Sweden Study. Cancer Res. 64(8), 2918-2922 (2004).
19. Sun J, Wiklund F, Zheng SL et al.: Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk. J. Natl. Cancer Inst. 97(7), 525-532 (2005).
20. Esteban J, Garcia-Calvo G, Jimenez-Castillo P, Soriano F: Failure of gram stain to detect Propionibacteruim acnes in specimens from clinically significant infections. J. Clin. Microbiol. 34(8), 2051 (1996).
21. Kamisango K, Saiki I. Tanio, Y et al.: Structures and biological activities of peptidoglycans of Listeria monocytogenes and Propionibacterium acnes. J. Biochem. (Tokyo) 92(1), 23-33 (1982).
22. Burkhart CG, Burkhart CN, Lehman PF: Acne: a review of immunologic and microbiological factors. Postgrad. Med. J. 75, 328-331 (1999).
23. Willen M, Holst E, Myhre EB, Olsson AM: The bacterial flora of the genitourinary tract in healthy fertile men. Scand. J. Urol. Nephrol. 30, 387-393 (1996).
24. Bowie WR, Pollock HM, Forsyth PS etal.: Bacteriology of the urethra in normal men and men with nongonococcal urethritis. J. Clin. Microbiol. 6(5), 482-488 (1977).
25. Shannon BA, Cohen RJ, Garrett KL: PCR-based identification of Propionibacterium acnes types isolated from the male urinary tract: evaluation of adolescents, normal adults and males with prostate pathology. BJU Int. (In Press).
26. McDowell A, Valanne S, Ramage G et al.: Propionibacterium acnes types I and II represent phylogenetically distinct groups. J. Clin. Microbiol. 43(1), 326-334 (2005).
27. Jakab E, Zbinden R, Gubler J, Ruef C, von Graevenitz A, Krause M: Severe infections caused by Propionibacterium acnes: an underestimated pathogen in late postoperative infections. Yale J. Biol. Med. 69(6), 477-482 (1996).
28. Webster GF: Inflammation in acne vulgaris. J. Am. Acad. Dermatol. 33, 247-253 (1995).
29. Cummins CS, Linn DM: Reticulostimulating properties of killed vaccines of anaerobic coryneforms and other organisms. J. Natl. Cancer Inst. 59(6), 697-1708 (1977).
30. Norris JFB, Cunliffe WJ: A histological and immunocytochemical study of early acne lesions. Br. J. Dermatol. 118, 651-659 (1988).
31. Jeremy AHT, Holland DB, Roberts SG, Thomson KE, Cunliffe WJ: Inflammatory events are involved in acne lesion initiation. J. Invest. Dermatol. 121, 20-27 (2003).
32. McClinton S, Eremin O, Miller D: Inflammatory infiltrate in prostatic hyperplasia - evidence of a host response to intraprostatic spermatozoa? Br. J. Urol. 65, 606-610 (1990).
33. McClinton S, Miller ID, Eremin O: An immunohistochemical characterisation of the inflammatory cell infiltrate in benign and malignant prostatic disease. Br. J. Cancer 61, 400-403 (1990).
34. Cohen RJ, Beales MP, McNeal JE: Prostate secretory granules in normal and neoplastic prostate glands: a diagnostic aid to needle biopsy. Hum. Pathol. 31(12), 1515-1519 (2000).
35. Schaller M, Loewenstein M, Borelli C et al.: Induction of a chemoattractive proinflammatory cytokine response after stimulation of keratinocytes with Propionibacterium acnes and coproporphyrin III. Br. J. Dermatol. 153(1), 66-71 (2005).
36. Nagy I. Pivaresi A, Koreck A, Szell M, Urban E, Kemeny L: Distinct strains of Propionibacterium acnes induce selective human β-defensin-2 and interleukin-8 expression in human keratinocytes through Toll-like receptors. J. Invest. Dermatol. 124(5), 931-938 (2005).
37. Kalis C, Gumenscheimer M, Freudenberg N et al.: Requirement for TLR9 in the immunomodulatory activity of Propionibacterium acnes. J. Immunol. 174 (7), 4295-4300 (2005).
38. Brook I: Pathogenicity of Propionibacterium acnes in mixed infections with facultative bacteria. J. Med. Microbiol. 34, 249-252 (1991).
39. Galobardes B, Davey Smith G, Jeffreys M, Kinra S, McCarron P: Acne in adolescence and cause-specific mortality: lower coronary heart disease but higher prostate cancer mortality: the Glasgow Alumni Cohort Study. Am. J. Epidemiol. 161(12), 1094-1101 (2005).
40. Giles GG, Sever G, English DR et al.: Early growth, adult body size and prostate cancer risk. Int. J. Cancer 103, 241-245 (2003).
41. Zaluga E: Skin reactions to antigens of Propionibacterium acnes in patients with acne vulgaris treated with autovaccine. Ann. Acad. Med. Stetin. 44, 65-85 (1998).